- Home
- MPLN vs DERM Comparison
MPLN vs DERM Comparison
Compare MPLN & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLN
- DERM
- Stock Information
- Founded
- MPLN 1980
- DERM 2014
- Country
- MPLN United States
- DERM United States
- Employees
- MPLN N/A
- DERM N/A
- Industry
- MPLN Business Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- MPLN Consumer Discretionary
- DERM Health Care
- Exchange
- MPLN Nasdaq
- DERM Nasdaq
- Market Cap
- MPLN 99.9M
- DERM 107.0M
- IPO Year
- MPLN N/A
- DERM 2021
- Fundamental
- Price
- MPLN $7.00
- DERM $5.37
- Analyst Decision
- MPLN Hold
- DERM Strong Buy
- Analyst Count
- MPLN 2
- DERM 3
- Target Price
- MPLN $25.00
- DERM $9.50
- AVG Volume (30 Days)
- MPLN 84.7K
- DERM 148.5K
- Earning Date
- MPLN 11-05-2024
- DERM 11-12-2024
- Dividend Yield
- MPLN N/A
- DERM N/A
- EPS Growth
- MPLN N/A
- DERM N/A
- EPS
- MPLN N/A
- DERM N/A
- Revenue
- MPLN $942,614,000.00
- DERM $57,771,000.00
- Revenue This Year
- MPLN N/A
- DERM N/A
- Revenue Next Year
- MPLN $1.07
- DERM $37.38
- P/E Ratio
- MPLN N/A
- DERM N/A
- Revenue Growth
- MPLN N/A
- DERM N/A
- 52 Week Low
- MPLN $4.80
- DERM $2.85
- 52 Week High
- MPLN $69.20
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- MPLN 41.66
- DERM 47.77
- Support Level
- MPLN $4.80
- DERM $5.05
- Resistance Level
- MPLN $9.15
- DERM $5.60
- Average True Range (ATR)
- MPLN 0.91
- DERM 0.39
- MACD
- MPLN -0.14
- DERM -0.02
- Stochastic Oscillator
- MPLN 49.89
- DERM 43.02
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.